This report describes and evaluates the global food emulsifiers market. It covers three five-year periods, including 2015 to -2020, termed the historic period, 2020-2025 forecast period and 2025-2030 a further forecast period.
LONDON, Oct. 13, 2021 (GLOBE NEWSWIRE) -- According to The Business Research Company’s research report on the food emulsifiers market, the global food emulsifiers market is expected to grow from $2.76 billion in 2020 to $2.99 billion in 2021 at a compound annual growth rate (CAGR) of 8.3%. The growth in the food emulsifiers market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The food emulsifiers market is expected to reach $4.07 billion in 2025 at a CAGR of 8%.
The food emulsifiers market consists of sales of food emulsifier products and related services by entities (organizations, sole traders, and partnerships) whose products are used as surface-active agents that act as a boundary between two insoluble fluids, such as water and oil, enabling them to be blended into stable emulsions. Food emulsifiers are added in bread, salad, dressings, sauces, ice creams, puddings, and various other food items to reduce stickiness, control crystallization, and prevent separation.
The main types of food emulsifiers are lecithin, monoglyceride, diglyceride, and derivatives, sorbitan ester, polyglycerol ester, and others. Lecithin is used in food applications as a lubricant, aerating agent, and viscosity transformer. The lecithin emulsifier's molecular structure makes it a good emulsifier for the interaction of water and oil. The food emulsifiers are either natural or synthetic and are available in different forms such as fine powder, hydrate. Food emulsifiers are used in various applications such as dairy and frozen products, bakery, meat, poultry and seafood, beverage, confectionery, and others.
The Business Research Company’s report titled Food Emulsifiers Global Market Report 2021 - By Type (Monoglyceride, Diglyceride, And Derivatives, Sorbitan Ester, Polyglycerol Ester), By Nature (Natural, Synthetic), By Form (Fine Powder, Hydrate ), By Application (Dairy And Frozen Products, Bakery, Meat, Poultry, And Seafood, Beverage, Confectionery, Others), COVID-19 Growth And Change covers major food emulsifiers companies, food emulsifiers market share by company, food emulsifiers manufacturers, food emulsifiers market size, and food emulsifiers market forecasts. The report also covers the global food emulsifiers market and its segments.
Request For A Sample Of The Global Food Emulsifiers Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5350&type=smp
Food emulsifier manufacturers are using clear emulsion technology for safe and allergen-free emulsification of food products including beverages, nootropics, edibles, nutraceuticals, and topical. Clear emulsion technology features multiple benefits for food product developers including stability, safety, bioavailability, homogeneity, seamless integration, and others. For instance, in 2020, US-based water-soluble emulsion technology company, SORSE Technology developed SORSE Clear, a clear emulsion with a minimal sensory profile that is made with allergen-free and vegan-friendly ingredients.
Major players in the food emulsifiers industry are Dupont Nutrition And Biosciences, Palsgaard A/S, Riken Vitamin Co. Ltd., Cargill, Estelle Chemicals Pvt. Ltd., Kerry Group Inc., Tate & Lyle, Corbion N.V., Lonza Group Ltd., BASF SE, Puratos Group, Koninklijke DSM N.V., Beldem S.A., Lecico GmbH, Lasenor Emul, S.L., and ABITEC Corporation.
In December 2019, RPM International Inc., a US-based manufacturer of specialty sealants, coatings, and building materials acquired Profile Food Ingredients, LLC through its edible coatings business, Mantrose-Haeuser Co., Inc. for an undisclosed amount. Through this acquisition, Mantrose-Haeuser Co. will be able to grow its sales of specialty ingredients in the food industry and expand its international market. Profile Food Ingredients, LLC is a US-based manufacturer of dry stabilizers and emulsifier blends for the food industry.
Europe was the largest region in the food emulsifiers market in 2020. Asia Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the food emulsifiers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Food Emulsifiers Global Market Report 2021 – COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provide food emulsifiers market overviews, food emulsifiers market analyze and forecast market size and growth for the whole market, food emulsifiers market segments and geographies, food emulsifiers market trends, food emulsifiers market drivers, food emulsifiers market restraints, food emulsifiers market leading competitors’ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.
The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here Is A List Of Similar Reports By The Business Research Company:
Food Ingredients Global Market Report 2021 - By Product Type (Starches, Vegetable Oils And Fats, Natural Sweeteners, Enzymes And Antioxidants, Natural Flavorings And Colours, Functional Ingredients), By Function (Sweeteners, Emulsifier, Flavors And Color Additives, Preservatives, Fat Replacers, Nutrients, Stabilizers, Thickeners, Binders, And Texturizers, pH Control Agents And Acidulants), By Application (Pharmaceuticals, Food And Beverages, Animal Feed), COVID-19 Growth And Change
Starch Derivatives Global Market Report 2021 - By Type (Glucose Syrup, Modified Starch, Maltodextrin, Hydrolysates, Cyclodextrin), By Raw Material (Corn, Cassava, Potato, Wheat), By Form (Dry, Liquid), By Application (Binder, Thickener And Stabilizer, Sweetener, Lustering Agent, Powdering Agent, Fish Culture Feed, Expanded Feed, Caking Agent, Dehumidification Agent), By End-User Industry (Food And Beverage, Medical Industry, Chemical Industry, Personal Care And Hygiene Industry, Paper And Pulp Industry), COVID-19 Growth And Change
Food And Beverage Testing Kits Global Market Report 2021 - By Product (Consumables, Equipment), By Application (Meat, Poultry, Seafood, Dairy, Processed Foods, Fruits And Vegetables), By Technology (Traditional, Rapid), By Contaminants Type (Pathogens, GMOs, Pesticides, Toxins), COVID-19 Growth And Change
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
Our call of the day says investors have been selling high-beta names too hard, because they're about to enter their biggest month.
BridgeBio Pharma said Monday its Pfizer-rivaling heart disease drug failed in a late-stage test — and BBIO stock crashed to a record low.
The drugmaker says its acoramidis trial for ATTR-CM treatment didn't meet primary endpoints, sending the stock plummeting.
As we get ready to turn the page on 2021, I can't help but note how we've witnessed a pretty substantial market bifurcation in stocks over the past couple of quarters. Below are four stocks that I believe are likely to find their way into my portfolio in 2022. A year ago, I was completely against electric vehicle (EV) manufacturer Nio (NYSE: NIO).
Since the Great Recession officially ended in 2009, growth stocks have been the driving force on Wall Street. Low lending rates, massive government spending, and the Federal Reserve providing an abundant pool of cheap capital have incentivized businesses to hire, innovate, and acquire other companies. The chickens are now coming home to roost in terms of runaway inflation, and though the Fed has indicated rate hikes are coming to combat high prices, effects won't be felt right away.
The dividends for such stocks are pretty much their only attraction. On the other hand, you can find dividend stocks that are anything but boring and stodgy. Here are three dividend stocks that soared more than 50% in 2021 and are still great buys.
It's been a dreadful year for Citigroup (NYSE: C) in terms of stock price performance, with shares of the megabank down about 1% this year. The KBW Nasdaq Bank Index, which tracks large bank stocks, is up nearly 35% this year, showing just how much Citigroup has lagged the broader sector. Trading at beaten-down levels, can Citigroup turn it around in 2022?
On Dec. 16, high-end electric pickup and SUV maker Rivian Automotive (NASDAQ: RIVN) reported its first-ever quarterly results since going public through its recent IPO. The company delivered 11 electric vehicles (EVs) in total during the third quarter of 2021, bringing in approximately $1 million in revenue. Meanwhile, its market capitalization (market cap) was a princely $100 billion at the time of the quarterly release.
Web 3.0 is widely considered to be the next frontier of internet technology, making the metaverse a golden macrotrend for retail investors. The metaverse refers to an easily scalable real-time virtual reality or mixed reality world, comprising several interoperable, immersive, and interactive 3D environments. The metaverse is also expected to maintain all relevant information about payments, identity, and history across user sessions.
ClearBridge Investments, an investment management firm, published its “Small Cap Value Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here. The ClearBridge Small Cap Value Strategy outperformed the Russell 2000 Value Index, the Strategy’s benchmark, during the third quarter of 2021. You can take a look at the fund’s […]
Sorrento Therapeutics Inc. announced Monday a contract for the sale and distribution of up to 10 million its Covistix rapid COVID-19 virus detection tests in Mexico. That follows a previously announced deal for up to 5 million Covistix tests in Mexico, bringing the total number of tests to 15 million. The biopharmaceutical company said independent clinical testing of Covistix by a Mexico-based national institute showed a "very high sensitivity" of around 90% in an "all-comers" population, includ
If you have $100 at the ready not needed for bills or emergencies and a brokerage that allows fractional share purchases, you have enough to buy into the following pair of no-brainer stocks right now. Palantir Technologies (NYSE: PLTR) is the Liam Neeson of data analytics stocks: It has a very particular set of skills that were acquired over a very long career. The U.S. military is also a prime customer, using Palantir's technology to coordinate millions of troops around the world.
Investors in Nio (NYSE: NIO) have been on a roller-coaster ride in 2021, but most of that ride has been downhill. As of the close of trading on Friday, shares of the Chinese electric vehicle (EV) company were down by around 54% from its highest-ever trading price of $66.99 in early January and off by more than 37% year to date. Among other issues, investors are concerned about the rapidly spreading omicron COVID-19 variant and its possible impact on the global economy, ongoing semiconductor chip shortages, increasing U.S. regulatory scrutiny on foreign companies, and fears that a debt default by massive Chinese property developer Evergrande Group might set off a financial crisis in Nio's home market.
With a market cap of $1.3 billion and trailing revenue of 47.2 million Canadian dollars ($36.5 million), Sundial is neither profitable nor rapidly growing. Let's consider one argument in favor of buying Sundial stock and one argument against it to determine if it's a good choice to add to your portfolio. Alex Carchidi: Though it's a risky stock to be sure, Sundial's turnaround story is on the verge of bearing fruit.
When you leave a job, and an IRA rollover is only one way to preserve the money’s tax-deferred status, and it's not always the best.
On Friday, Chinese regulators released a draft of new policies for companies wishing to offer shares in foreign countries. It's not providing much of a boost.
Sorrento Therapeutics Inc. said Monday that "initial" laboratory testing of its Covistix COVID-19 virus rapid antigen detection test "significantly outperforms" in the detection of the omicron variant. The stock slipped 1.1% in morning trading. The company said Covistix, which is currently approved in Mexico and Brazil and is CE marked in Europe, was able to detect the omicron N protein "at a significantly lower level" than other commercially available tests in a laboratory setting, and in an in
In the last batch, taxpayers got close to $1,200 back, on average.
This mix of industrial and renewable energy companies could be a great way to generate passive income next year.
These last few weeks of 2021 have seen increased market volatility. Along with Omicron fears, the market fluctuations have come just as Wall Street is digesting the fact of a new Fed policy in the New Year, including the tightening up of monetary policy and at least one, probably more, interest rate hikes. The Fed’s easy money has been supportive for the better part of the past decade or more, and investors are rightly wondering how the market will adapt. Looking ahead, Wedbush’s Daniel Ives is